Focus on Trial Master File management, document quality, inspection readiness and the systems and controls supporting clinical-trial records.

Follow a fixed, role-focused curriculum built around the knowledge required for your target role.
On the AIDIFY platform, start any course not already covered by a purchased license and confirm the use of one token. Each token unlocks one course.
Learn at your own pace with 6 months of access to all included courses.

















Your purchase includes 3 course tokens.
Browse the full AIDIFY catalog, choose a course on the platform, click Start course and confirm that you want to use a token.

Anna Buczyńska-Borowy is a highly respected figure in the field of data protection and privacy, renowned for her expertise and contributions to the industry. With a distinguished career spanning decades, Anna has established herself as a leading authority in this rapidly evolving domain.
Currently serving as the Managing Director of AB Advisory, Anna brings a wealth of knowledge and experience to her role. In addition to her leadership at AB Advisory, Anna holds the esteemed position of Vice President of the Board at the Józef Wybicki Foundation, where she plays a pivotal role in driving initiatives focused on social impact and community development.
Anna's dedication to advancing data protection practices is evident through her role as the Founder and Lead Lecturer at the Academy of Data Protection (Akademia ODO), where she imparts her insights to the next generation of data protection professionals. As a Certified Lead Auditor for ISO 27001 and a Certified Data Protection Officer (IOD/DPO), Anna is committed to upholding the highest standards of privacy and security in her work.
As a member of the Committee for Personal Data Protection at the National Chamber of Commerce, Anna actively shapes policy discussions and advocates for best practices in data protection. Her involvement in industry initiatives such as "Art & Privacy" and "Women In ODO" (WIn ODO) underscores her dedication to promoting diversity and inclusion in the field.
Anna's contributions extend beyond her professional endeavors, as she is also the author of various publications, including "Szacowanie ryzyka dla ochrony danych osobowych na gruncie RODO. Od teorii do praktyki," a seminal work in the field of data protection.
With her comprehensive expertise and unwavering commitment to excellence, Anna Buczyńska-Borowy is a trusted authority and sought-after speaker at conferences and events worldwide, where she shares her insights and best practices on topics related to data protection and privacy. Her impact on the industry is profound, and her dedication to advancing data protection standards continues to inspire professionals globally.

Excellent communicator with can-do attitude and strong desire to learn. Project Manager with line management responsibilities focused on quality. Currently fulfilling the role of an Oversight Portfolio Manager working on a governance level, responsible for several studies of one client and oversight and support a group of CTMs allocated for those projects. Client oriented and dedicated team player. Long-term goal is to have an independent and responsible position as a global project director. Experience in pharmaceutical marketing, medical affairs and clinical trials gained in pharma companies and CROs.Founder and member of Polish Pharmaceutical Students’ Association. Member and head of the training group at Polish Association for Good Clinical Practice (GCPpl). Pharmacist with strong interest in clinical pharmacy. Academic teacher delivering lectures related with clinical trials.
Certificates: Soft Skills Trainer Certificate, Prince2 Foundation Training Certificate, Barnett GCP Certificate. Laureate and winner of a 3rd place of the national competition “Leaders of Clinical Trials (2021)” in the category Project Manager. Scholar of Leslaw A. Paga Foundation in the program “Healthcare Leaders”.
Privately foodie and enthusiast of cooking, travelling and fantasy books.

She has been involved in the clinical research industry since 2015. She currently works for a global pharmaceutical company as a Manager in the Clinical Documentation team, where her main role is FSO Operations Lead.
She places high value on personal development and the quality of performed activities, which makes her a valued member of project teams. She has operational experience gained in global CROs and pharmaceutical companies. She has worked on both investigational and medical device projects in a variety of therapeutic areas.
From the very beginning of her work in clinical research, she has struggled with the complex nature of clinical trial documentation and TMF, which she continues to explore to this day.
In addition to her day job, she is actively involved in the academic community, initially as a coordinator and support to the manager of a post-graduate study in the clinical trial area. Currently, she is a lecturer at Conducting and Monitoring Clinical Trials and Associate Director in Third Party Processes & Operations.
This collaboration started after the previously completed postgraduate studies in Conducting and Monitoring Clinical Trials. Graduate of Nicolaus Copernicus University in Torun in the faculties of molecular biology and environmental protection.
Although she started her professional life at the Central Forensic Laboratory of the Police, she now finds herself perfectly at work in clinical project activities and now she is conducting other types of investigations.


Agnieszka is graduated from Faculty of Biology, University of Warsaw, where she also had continued research study earning PhD in Molecular Biology. Mastering the knowledge in life science field and developing transferable skills helped her in clinical research field. Currently, she is a GCP Expert with over 15 years of experience in clinical research as a Contract Research Associate, Trainer and Clinical Quality Manager. Responsible for inspection readiness activities, inspection preparation, facilitation and follow up. Participated in several on-site or remote FDA, EMA and local Health Authority inspections as well as in number of audits when working for CROs or pharmaceutical companies. Actively involved in in-dept root cause analysis of the audit or inspections findings, effective CAPA plans preparation, their follow up and effectiveness check.
Agnieszka is process-oriented, especially in terms of the processes at the site level, as she believes that a good set up of the investigational site for clinical trial is indispensable to its success.
As a member Training Section of the Association for Good Clinical Practice in Poland (GCPpl), she promotes knowledge about clinical trials and ICH GCP in the medical and pharmaceutical industries and likes sharing experience with others.

Lucas is an accomplished clinical trial quality expert with nearly two decades of experience in Good Clinical Practice (GCP) across SMO and CRO environments. With a strong background in leadership and oversight, he has held senior responsibilities in Quality Assurance and Clinical Quality, ensuring that clinical trial activities meet high standards of regulatory compliance, patient safety and data integrity. quality management systems within the pharmaceutical industry. What gives me him unique perspective on this subject is his dual experience - having had the privilege of working both within the Polish Regulatory Authority and on the industry side, collaborating with organizations that plan and conduct clinical trials. This dual background allows him to understand the expectations of regulators while deeply appreciating the practical, day-to-day realities of trial operations.
His expertise includes an advanced understanding of global clinical trial regulations and practical experience overseeing, preparing for and hosting major regulatory inspections, including those conducted by the FDA, MHRA and BfArM. He has worked across multiple quality functions, including Quality Management System development, implementation and maintenance; audit and compliance activities; root cause analysis; and corrective and preventive action planning.
His specialist areas include building and maintaining robust Quality Management Systems, designing annual audit programmes, conducting vertical, horizontal, directed, routine and for-cause GCP audits, managing GCP vendor audits and oversight, and supporting inspection readiness. This breadth of experience enables him to provide practical, regulation-focused insight into clinical trial quality and compliance.
Get 10 CORE courses, 3 electives and 6 months of access in one focused program.